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Abstract
Background: The potential risks associated with hip resurfacing arthroplasty (HRA) are controversial and
underestimated. The aim of this study was to explore intermediate-term trends for the levels of cobalt (Co),
chromium (Cr), and molybdenum (Mo) ions after HRA.
Methods: Forty patients who underwent HRA from October 2005 to December 2010 were recruited to this study.
The serum levels of metal ions were examined preoperatively and 3, 12, 24, and 60 months after surgery. Trends
and differences in levels of metal ions with respect to sex, operated side, and body mass index (BMI) were analyzed.
Results: There were no significant differences in levels of Cr, Co, and Mo at each time point with respect to sex,
operated side, and BMI (p > 0.05). The postoperative levels of Cr, Co, and Mo ions were significantly higher than the
preoperative levels across sex, operated side, and BMI groups. Postoperative levels of Cr, Co, and Mo peaked at 12,
24, and 60 months, respectively. Cr levels peaked earlier (at 12 months) in the overweight (BMI ≥25 kg/m2) group
compared to the normal-weight group (BMI <25 kg/m2), Co levels (at 12 months) peaked in women compared to
men, and Mo levels (at 3 months) peaked in the bilateral HRA group compared to the unilateral HRA group.
Conclusions: Serum levels of Cr, Co, and Mo increased significantly after HRA. Cr levels peaked earlier in the
overweight patients, Co levels peaked in women, and Mo levels peaked in patients who underwent bilateral HRA.
However, there were no significant differences with respect to sex, operated side, and BMI.
Keywords: Hip resurfacing arthroplasty, Metal ion, Secular trends, Follow-up, Inductively coupled plasma mass
spectrometry
Introduction
Hip resurfacing arthroplasty (HRA) has recently been
extensively used in young, active patients with osteoarth-
ritis or other degenerative diseases of the hip joint [1–5].
However, the metal-on-metal prosthesis gradually releases
cobalt (Co), chromium (Cr), and molybdenum (Mo) ions.
The metal ions may disseminate into the surrounding soft
tissues and even into the body [6]. Currently, the factors
influencing the serum levels of metal ions remain unclear.
Several adverse effects of metal ions have been reported,
including local soft tissue reactions, pseudotumor forma-
tion, systemic effects, and elevated deposits of metal ions
in target organs [7–11]. Studies performed in European
and American countries showed that the location of the
prosthesis is associated with the wear rate of the hip joint
simulator [12]. However, the relationships between the
levels of metal ions released following HRA and patient
sex, operated side, and body mass index (BMI) remain
unknown.
The purpose of the study was to assess the 5-year
trends in the levels of metal ions released and to analyze
the relationships between the levels of metal ions and
patient sex, operated side, and BMI after HRA. This is
the first report of 5-year changes in Cr, Co, and Mo
levels in patients who had undergone HRA in China.
Patients and methods
Patient selection
The ethics committee of Tianjin First Central Hospital
approved the study, and written informed consent was
obtained from all participants during recruitment.
From October 2005 to December 2010, 40 patients who
were diagnosed with osteoarthritis and inflammatory
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degenerative diseases of the hip joint underwent HRA
performed by Wenxue Jiang in the Department of
Orthopedics, Tianjin First Central Hospital, China. The
diagnosis of osteoarthritis was established based on the
patient’s symptoms and plain radiography performance;
similarly, the diagnosis of inflammatory degenerative dis-
eases was also based on the patient’s symptoms and plain
radiography performance.
The inclusion criteria of the study were (1) patients
with osteonecrosis of the femoral head with Association
of Research Circulation Osseous (ARCO) grade IB (de-
fined as the range of necrosis between 15 and 30 % on
MRI), IC (defined as a range of necrosis of ≥30 % on
magnetic resonance imaging (MRI)), IIC (defined as a
range of necrosis of ≥30 % and the presence of a cystic
lesion on MRI), and grade IV (defined as flattening of
the femoral head, narrowing of the joint space, and
sclerosis of the acetabulum on plain radiography; (2) pa-
tients with developmental dysplasia of the hip (DDH)
with Crowe grade I (defined as dislocation of the femoral
head of <50 %), Crowe grade II (defined as displacement
of the proximal femur between 0.1 and 0.15 % of pelvic
height), or Crowe grade III (defined as the displacement
of proximal femur between 0.15 and 0.20 % of pelvis
height or dislocation of femoral head between 75 and
100 %); (3) young, active patients between 20 and
64 years of age; (4) patients with severe hip joint pain
that strongly affected the patient’s daily activities; (5)
failed trials of nonoperative treatments; (6) patients with
favorable bone mass based on the proximal femur; (7)
patients with no deformities in the proximal femur; and
(8) patients with normal liver and renal function [13].
The exclusion criteria were (1) severe proximal femur
osteoporosis based on the Singh index (defined as Singh
index ≥4) [14], (2) grade IV dysplasia based on the
Crowe classification [15], (3) known allergy to metal, (4)
bone tumors, (5) liver or renal dysfunction, and (6)
patients with diabetes, gout, or other diseases. All assess-
ments were performed by PC, who did not attend the
treatments.
Surgical procedure
The operation was performed with the patient in the
lateral decubitus position with the operated side facing up,
as recommended by McMinn et al. [16]. After acetabular
preparation, the acetabular component was impacted until
fully seated, with a position of 40° abduction and 20° ante-
version. Pressure was applied to stabilize the acetabular
prosthesis. On the femoral head side, any cystic lesion was
resected radically. The femoral prosthesis was inserted
and fixed with bone cement. The femoral neck was sup-
ported with a band to avoid forming a notch at the junc-
tion of the femoral head and neck (Figs. 1 and 2).
Measurement of metal ion levels in serum
Whole-blood samples were collected preoperatively and at
3, 12, 24, and 60 months postoperatively to assess the
levels of Co, Cr, and Mo ions. The fasting blood sample
was collected in a 10-ml plastic vacuum serum separator
blood collection tube. The first 10 ml of blood was dis-
carded to prevent metal contamination from the needle.
The second 10 ml of blood was centrifuged at 4000 rpm
for 5 min after incubating 30 min. The serum was drawn
into a plastic tube with a sealed cap using a plastic suction
device and was then stored at −20 °C. Subsequently,
0.5 ml of nitric acid was added to 0.5 ml of serum, and the
mixture was incubated for 24 h; 4 ml of deionized distilled
water was then added into the mixture and the volume
was measured. After centrifuging at 8000 rpm for 3 min,
the supernatant was removed and was used to measure
the levels of Co, Cr, and Mo ions in triplicate. The serum
levels of Co, Cr, and Mo ions were determined using an
inductively coupled plasma mass spectrometer at the
Experimental Center of Nankai University, China. We also
assessed the preoperative renal function of all patients by
measuring the serum urea and creatinine levels.
Statistical analysis
Metal ion levels were expressed as the median and range,
due to the asymmetrical distribution of the metal ion levels.
Differences in the levels of metal ions between men
and women, patients who had undergone unilateral and
bilateral HRA, and those with body mass indexes (BMI)
<25 kg/m2 and BMI ≥25 kg/m2 were analyzed using a non-
parametric Mann-Whitney U test. Changes in time trends
of metal ion levels were analyzed using the Kruskal-Wallis
test. Age was represented as mean ± standard deviation.
Statistical significance was set at p < 0.05. All statistical ana-
lyses were performed using SPSS software (version 15.0;
SPSS Inc. Chicago, IL).
Results
Clinical characteristics of patients
In all, 40 patients were included in this study, including
19 (47.5 %) men and 21 (52.5 %) women. The mean age
at surgery was 49.2 years overall (range, 26–64 years),
46.2 years in men (range, 26–58 years), and 52.0 years in
women (range, 26–64 years), p = 0.062. The mean
follow-up time was 24.1 months (range, 3–76 months).
All patients underwent HRA with a metal-on-metal
prosthesis. Twenty-eight patients (70 %) underwent bi-
lateral resurfacing, and 12 (30 %) patients underwent
unilateral resurfacing; there were no significant differ-
ences in the operated side between men and women
(Table 1). The levels of serum urea and creatinine did
not change during the study period.
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Metal ion levels over time by sex, laterality, and BMI
As shown in Table 2, the levels of Cr, Co, and Mo at
each time point were not significantly different when
sex, operated side, and BMI groups were considered
(p > 0.05). However, Cr levels were higher in women
than in men (1.20 ng/ml vs. 1.88 ng/ml; p = 0.040) at
24 months postoperatively and in the BMI <25 kg/m2
group than in the BMI ≥25 kg/m2 group preoperatively
(0.73 ng/ml vs. 0.66 ng/ml; p = 0.037).
Fig. 1 The process of surgical operation. a To perform borehole and bearizing on the center of the femur head under the conducting by a
director. b To resect the acetabular labrum and burr until bleeding on the cartilage articularis, to impact the appropriate acetabular prosthesis
with a position of 40° abduction and 20° anteversion, and to pressure for stabilization. c To burr the femur head using the barrel file and to resect
the cystic lesion. d To embed the femoral prosthesis and fix with bone cement. Intraoperative photograph showing the embedded femoral
prosthesis fixed with bone cement
Fig. 2 The X-ray plain film of prosthesis location. The X-ray plain film
shows that the location of prosthesis is good during the operation.
Postoperative radiograph showing typical hip resurfacing arthroplasty
in the anteroposterior view
Table 1 Demographic and clinical characteristics of patients
Characteristic Men Women Total p
Number, n (%) 19 21 40 –
Age, year, mean (SD) 46.2 (9.5) 52.0 (9.6) 49.2 (9.8) 0.062
BMI, kg/m2, mean (SD) 25.3 (3.7) 24.4 (2.6) 24.9 (3.2) 0.409
Diagnosis, n (%) 0.085
ONFH 9 (47.4) 6 (28.6) 15 (37.5)
OA 2 (10.5) 0 2 (5)
DDH 4 (21.1) 10 (47.6) 14 (35)
RA 1 (5.3) 3 (14.3) 4 (10)
AS 3 (15.8) 0 3 (7.5)
Others 0 2 (9.5) 2 (4.0)
Operated side, n (%) 0.836
Unilateral 13 (68.4) 15 (71.4) 28 (70)
Bilateral 6 (31.6) 6 (28.6) 12 (30)
Prosthesis company, n (%) 0.464
Conserve Plus 12 (63.2) 10 (47.6) 22 (55)
BHR 2 (10.5) 6 (28.6) 8 (20)
BMHR 3 (15.8) 4 (19) 7 (17.5)
Depuy ASR-TM 2 (10.5) 1 (4.8) 3 (7.5)
SD standard deviation, BMI body mass index, ONFH osteonecrosis of the
femoral head, OA osteoarthritis, DDH developmental dysplasia of the hip,
RA rheumatoid arthritis, AS ankylosing spondylitis
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Trends for metal ion levels during the 5-year follow-up
Overall, the postoperative serum levels of Cr, Co, and
Mo were significantly higher than the preoperative levels
across sex, operated side, and BMI groups. Postoperative
serum Cr levels peaked at 12 months, Co levels peaked
at 24 months, and Mo levels peaked at 60 months. The
respective ion levels peaked at 12, 60, and 60 months for
men and 24, 12, and 60 months in women; 12, 24, and
12 months in the unilaterally operated group and 24, 60,
and 3 months for the bilaterally operated group; and 24,
24, and 60 months for the BMI <25 kg/m2 group and
12, 60, and 60 months for the BMI ≥25 kg/m2 group (all
p < 0.05). The trends for Cr, Co, and Mo levels before
and after HRA are summarized in Table 3.
Complications and survival rate of prostheses after HRA
Only one patient experienced femoral neck fracture after
HRA among all 40 patients during follow-up, which was
Table 2 Levels of metal ions over time by sex, side, and body mass index
Time point Cr p Co p Mo p
Preoperation
Men 0.70 (0.03) 0.949 0.72 (0.04) 0.949 0.82 (0.02) 0.564
Women 0.70 (0.03) 0.74 (0.03) 0.83 (0.02)
Unilateral 0.68 (0.03) 0.478 0.72 (0.04) 0.848 0.82 (0.02) 0.564
Bilateral 0.72 (0.02) 0.74 (0.03) 0.83 (0.02)
BMI <25 kg/m2 0.73 (0.02) 0.037 0.71 (0.02) 0.196 0.83 (0.01) 0.518
BMI ≥25 kg/m2 0.66 (0.02) 0.76 (0.04) 0.81 (0.02)
3 months
Men 1.06 (0.16) 0.668 1.55 (0.56) 0.116 6.26 (1.41) 0.253
Women 1.30 (0.29) 2.01 (0.57) 7.23 (0.88)
Unilateral 1.15 (0.21) 0.237 1.97 (0.50) 0.866 6.16 (0.78) 0.176
Bilateral 1.31 (0.22) 1.21 (0.15) 8.86 (2.01)
BMI <25 kg/m2 1.16 (0.22) 0.253 2.97 (1.05) 0.288 4.68 (0.56) 0.235
BMI ≥25 kg/m2 1.20 (0.22) 1.44 (0.36) 7.41 (0.92)
12 months
Men 1.80 (0.52) 0.487 2.16 (0.59) 0.298 6.91 (1.06) 0.817
Women 1.81 (0.4) 3.19 (0.72) 7.10 (0.78)
Unilateral 1.67 (0.37) 0.713 2.32 (0.55) 0.327 7.35 (0.66) 0.540
Bilateral 2.06 (0.62) 3.50 (0.88) 6.33 (1.39)
BMI <25 kg/m2 3.03 (1.47) 0.243 3.41 (1.86) 0.322 6.86 (3.65) 0.493
BM I ≥25 kg/m2 1.61 (0.28) 2.60 (0.50) 7.03 (0.6)
24 months
Men 1.20 (0.39) 0.04 2.96 (0.78) 0.661 4.67 (0.42) 0.242
Women 1.88 (0.30) 3.09 (0.59) 5.55 (0.86)
Unilateral 1.53 (0.27) 0.236 3.00 (0.46) 0.693 4.84 (0.48) 0.324
Bilateral 2.08 (0.75) 3.26 (2.04) 7.23 (2.56)
BMI <25 kg/m2 1.85 (0.45) 0.938 3.40 (0.74) 0.721 4.35 (0.74) 0.276
BMI ≥25 kg/m2 1.47 (0.3) 2.81 (0.60) 5.75 (0.74)
60 months
Men 1.17 (0.11) 0.584 3.60 (0.62) 0.361 7.42 (0.57) 0.584
Women 1.24 (0.28) 2.52 (0.720 7.60 (1.32)
Unilateral 1.33 (0.28) 0.855 2.54 (0.70) 0.465 7.04 (1.25) 0.361
Bilateral 1.06 (0.06) 3.63 (0.66) 8.09 (0.67)
BMI <25 kg/m2 1.29 (0.24) 1.000 2.80 (0.63) 0.850 7.12 (1.1) 0.345
BMI ≥25 kg/m2 1.06 (0.08) 3.45 (0.87) 8.22 (0.65)
Data shown as mean (standard error)
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pathologically diagnosed as osteonecrosis of the femoral
head [10]. Except for this patient, no cases presented any
complication, including an anaphylactic reaction to the
metal ions, continuous pain in the groin, red/swollen
skin and/or pruritus around the prosthesis, or malig-
nancy. No surgery-related deaths occurred during the
follow-up period, and the overall survival rate of the
prostheses was 97.5 %.
Discussion
In this study, we found that postoperative levels of Cr,
Co, and Mo were significantly higher than preoperative
levels across sex, operated side, and BMI groups. There
were few significant differences in the levels of Cr, Co,
and Mo at each time point by sex, operated side, and
BMI groups, except that Cr levels were higher in women
than in men 24 months postoperatively and in the BMI
<25 kg/m2 group than in the BMI ≥25 kg/m2 group pre-
operatively. In addition, Cr levels peaked earlier in the
BMI ≥25 kg/m2 group at 12 months, Co levels peaked in
women at 12 months, and Mo levels peaked in the bilat-
eral group at 3 months.
HRA has recently been extensively applied in young
patients owing to a survival rate of 99 % and is the better
option for young patients than is total hip replacement
[17–24]. However, it has been established that the levels
of metal ions in circulation in vivo increase persistently
following HRA [25–27]. Researchers worldwide have
noted this issue, though the long-term clinical effects re-
main undetermined.
Daniel et al. [28] analyzed the whole-blood levels of
Co and Cr among 24 patients who had undergone
Table 3 Levels of metal ions over time by sex, laterality, and body mass index
Category Preoperation 3 months 12 months 24 months 60 months
Total
Cr, ng/ml 0.70 (0.02) 1.19 (0.17)* 1.80 (0.31)* 1.62 (0.25)* 1.20 (0.15)*
Co, ng/ml 0.73 (0.02) 1.79 (0.39)* 2.71 (0.48)* 3.04 (0.45)* 3.04 (0.49)*
Mo, ng/ml 0.82 (0.01) 6.78 (0.78)* 7.01 (0.62)* 5.21 (0.55)* 7.52 (0.73)*
Men
Cr, ng/ml 0.70 (0.03) 1.06 (0.16) 1.8 (0.52)* 1.2 (0.39)* 1.17 (0.11)*
Co, ng/ml 0.72 (0.04) 1.55 (0.56)* 2.16 (0.59)* 2.96 (0.78)* 3.6 (0.62)*
Mo, g/ml 0.82 (0.02) 6.26 (1.41)* 6.91 (1.06)* 4.67 (0.42)* 7.42 (0.57)*
Women
Cr, ng/ml 0.70 (0.03) 1.30 (0.29)* 1.81 (0.40)* 1.88 (0.30)* 1.24 (0.28)*
Co, ng/ml 0.74 (0.03) 2.01 (0.57)* 3.19 (0.72)* 3.09 (0.59)* 2.52 (0.72)*
Mo, g/ml 0.83 (0.02) 7.23 (0.88)* 7.1 (0.78)* 5.55 (0.86)* 7.6 (1.32)*
Unilateral
Cr, ng/ml 0.68 (0.03) 1.15 (0.21)* 1.67 (0.37)* 1.53 (0.27)* 1.33 (0.28)*
Co, ng/ml 0.72 (0.04) 1.97 (0.5)* 2.32 (0.55)* 3.00 (0.46)* 2.54 (0.7)*
Mo, g/ml 0.82 (0.02) 6.16 (0.78)* 7.35 (0.66)* 4.84 (0.48)* 7.04 (1.25)*
Bilateral
Cr, ng/ml 0.72 (0.02) 1.31 (0.22) 2.06 (0.62)* 2.08 (0.75)* 1.06 (0.06)*
Co, ng/ml 0.74 (0.03) 1.21 (0.15) 3.50 (0.88)* 3.26 (2.04) 3.63 (0.66)*
Mo, g/ml 0.83 (0.020 8.86 (2.01)* 6.33 (1.39)* 7.23 (2.56) 8.09 (0.67)*
BMI <25 kg/m2
Cr, ng/ml 0.73 (0.02) 1.16 (0.22) 3.03 (1.47) 1.85 (0.45)* 1.29 (0.24)*
Co, ng/ml 0.71 (0.02) 2.97 (1.05)* 3.41 (1.86) 3.40 (0.74)* 2.8 (0.63)*
Mo, g/ml 0.83 (0.01) 4.68 (0.56)* 6.86 (3.65) 4.35 (0.74)* 7.12 (1.1)*
BMI ≥25 kg/m2
Cr, ng/ml 0.66 (0.02) 1.20 (0.22)* 1.61 (0.28)* 1.47 (0.3)* 1.06 (0.08)*
Co, ng/ml 0.76 (0.04) 1.44 (0.36)* 2.60 (0.5)* 2.81 (0.6)* 3.45 (0.87)*
Mo, g/ml 0.81 (0.02) 7.41 (0.92)* 7.03 (0.6)* 5.75 (0.74)* 8.22 (0.65)*
Data shown as mean (standard error)
*Indicated p < 0.05 by nonparametric Kruskal-Wallis test. Data shown as mean (standard error)
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unilateral HRA and found that Co and Cr levels were
significantly increased after 1 year, followed by a de-
creasing trend until the sixth year. Yang et al. [25]
assessed the levels of Co and Cr in 21 patients who
underwent HRA and found a consistent increase in Co
and Cr serum levels; Co and Cr levels peaked at
6 months (increased by 7.8-fold for Co and 10.1-fold for
Cr) and at 9 months (increased by 4.7-fold for Co, and
7.8-fold for Cr), respectively, followed by a gradual
decline after 6 months (levels were 3.6-fold for Co and
5.1-fold for Cr at 24 months). Levine et al. [17] found
that the levels of Co and Cr ions were elevated in three
implant groups (hybrid group, CoCr group, and titanium
group) at all follow-up periods compared with those in
the control group, and the mean Cr levels for the hybrid
and CoCr groups were higher at 120 months compared
to baseline levels, with increases of 3.9-fold and 3.6-fold,
respectively. In contrast to these previous studies, we
found that the postoperative levels of metal ions were
elevated; the Cr level peaked at 12 months (increased by
1.6-fold) postoperatively, the Co level peaked at
60 months (increased by 3.2-fold), and the Mo level
peaked at 60 months (increased by 8.2-fold). Compared
to the results reported by Daniel et al. [27], our results
demonstrated the same peak time for Cr levels and a
delayed peak time for Co levels; however, the peak times
of Cr and Co levels were delayed compared to those in
the study reported by Yang et al. [26], in which the levels
of Cr and Co peaked at 6 months postoperatively. The
differences in peak time between the previous studies
and our study may be explained by differences in pros-
theses [18], patients (young) [26], and types of operation
(unilateral HRA) [28].
Previous studies showed that Cr levels were higher in
women than in men [17, 18, 29], but we found no differ-
ences in levels of Co and Mo between men and women.
In line with those studies, we observed an increased
level of Cr in women. However, we did observe an earl-
ier peak time for Co levels in women compared with
men. This difference may be explained partly by the
physiological differences between men and women.
The relationship of the levels of metal ions and the
operated side for HRA is disputed. Moroni et al. [19]
advocated that Cr levels were higher in patients who had
undergone bilateral HRA compared with patients who
had undergone unilateral HRA, though there was no
difference in levels of Co and Mo. deSouza et al. [20]
found that the level of Co was significantly increased (by
45 %) in patients who had undergone bilateral HRA.
However, a few studies reported no changes in metal ion
levels between those who underwent bilateral and unilat-
eral HRA [21–23]. Consistent with the findings in these
previous studies, there were no significant differences in
metal ion levels between patients who had undergone
bilateral and unilateral HRA in the present study. How-
ever, there was an earlier peak time for Mo ion level
(3 months) in the bilateral HRA group compared to that
in the unilateral HRA group. The reason is unknown.
Previous studies have demonstrated no significant re-
lationship between BMI and metal ion levels after HRA
[23, 30]. Consistent with these studies, we found no sig-
nificant differences in metal ion levels between the
normal-weight group and the overweight group postop-
eratively. However, Cr peaked earlier in the overweight
group than in the normal-weight group. The increased
load and wear of the hip joint in patients with a higher
BMI after HRA may partly explain the earlier peak for
Cr levels in the overweight group than in the normal-
weight group [23].
In this study, metal ion levels were measured using
inductively coupled plasma mass spectrometry that is
associated with high accuracy and less interference
and has been extensively applied to measure metal ion
levels. There are several limitations in this study. First,
there was a small sample size, as only 40 patients were
assessed. Second, over the follow-up period of 5 years,
measurements were only performed four times. There-
fore, further studies with a greater number of postop-
erative measurements and with larger numbers of
patients are necessary to confirm these findings.
Conclusion
Our study suggests that serum levels of Cr, Co, and Mo
increase significantly after HRA. Cr levels peaked earlier
in the overweight patients, Co levels peaked in women,
and Mo levels peaked in patients who underwent bilat-
eral HRA. However, there were no significant differences
with respect to sex, operated side, and BMI. A long-term
study on the levels of metal ions is necessary to improve
understanding of the effects of metal ions after HRA.
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